Literature DB >> 3177752

Critical assessment of supraomohyoid neck dissection.

J D Spiro1, R H Spiro, J P Shah, R B Sessions, E W Strong.   

Abstract

During a recent 5-year period, 115 patients had 131 supraomohyoid neck dissections. Eighty-one percent of these procedures were performed for squamous carcinoma. Seventy-nine percent of the primary tumors were located in the oral cavity and 16 percent arose in the oropharynx. Almost 80 percent of the necks dissected for primary squamous carcinoma were clinically N0, and occult nodal disease was discovered in 31 percent of these neck specimens. When the supraomohyoid neck dissection specimen showed no involvement, the overall incidence of treatment failure in the neck at 2-year follow-up was 5 percent. Almost all patients with occult squamous carcinoma in the supraomohyoid neck dissection specimen received postoperative radiotherapy, and the failure rate in the neck was 15 percent. When neck nodes were both clinically and pathologically involved, neck recurrence developed in 29 percent of the patients despite the addition of adequate postoperative radiotherapy. Among those patients with nonsquamous primary tumors and a pathologically negative supraomohyoid neck dissection specimen, there was only one subsequent treatment failure in the neck. Supraomohyoid neck dissection appears to be a valid staging procedure for clinically N0 patients with primary squamous carcinomas located in the oral cavity or oropharynx, with an appropriate yield of occult nodal disease, and infrequent treatment failure in the dissected neck when the supraomohyoid neck dissection specimen is pathologically uninvolved. When nodal disease is clinically obvious, treatment failure is more frequent, even with the addition of postoperative radiotherapy. The role of supraomohyoid neck dissection in this setting deserves further study.

Entities:  

Mesh:

Year:  1988        PMID: 3177752     DOI: 10.1016/s0002-9610(88)80293-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  23 in total

Review 1.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.

Authors:  Sandra Schmitz; Jean-Pascal Machiels; Birgit Weynand; Vincent Gregoire; Marc Hamoir
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-22       Impact factor: 2.503

Review 3.  Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.

Authors:  R A Ord
Journal:  Oral Maxillofac Surg       Date:  2012-05-13

4.  Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study.

Authors:  Moran Amit; Yoav Binenbaum; Kanika Sharma; Naomi Ramer; Ilana Ramer; Abib Agbetoba; Joelle Glick; Xinjie Yang; Delin Lei; Kristine Bjørndal; Christian Godballe; Thomas Mücke; Klaus-Dietrich Wolff; Dan Fliss; André M Eckardt; Chiara Copelli; Enrico Sesenna; Frank Palmer; Ian Ganly; Snehal Patel; Ziv Gil
Journal:  Head Neck       Date:  2014-07-24       Impact factor: 3.147

5.  Selective neck dissection in the management of squamous cell carcinoma of the upper digestive tract.

Authors:  P Ambrosch; L Freudenberg; M Kron; W Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

6.  An audit of one surgeon's experience of oral squamous cell carcinoma using a computerized malignancy database.

Authors:  J C Beirne
Journal:  Ann R Coll Surg Engl       Date:  1996-03       Impact factor: 1.891

Review 7.  Cancer of the oral cavity.

Authors:  Pablo H Montero; Snehal G Patel
Journal:  Surg Oncol Clin N Am       Date:  2015-04-15       Impact factor: 3.495

Review 8.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

9.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  L W T Alkureishi; Z Burak; J A Alvarez; J Ballinger; A Bilde; A J Britten; L Calabrese; C Chiesa; A Chiti; R de Bree; H W Gray; K Hunter; A F Kovacs; M Lassmann; C R Leemans; G Mamelle; M McGurk; J Mortensen; T Poli; T Shoaib; P Sloan; J A Sorensen; S J Stoeckli; J B Thomsen; G Trifiro; J Werner; G L Ross
Journal:  Ann Surg Oncol       Date:  2009-11       Impact factor: 5.344

10.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  Lee W T Alkureishi; Zeynep Burak; Julio A Alvarez; James Ballinger; Anders Bilde; Alan J Britten; Luca Calabrese; Carlo Chiesa; Arturo Chiti; Remco de Bree; Harry W Gray; Keith Hunter; Adorjan F Kovacs; Michael Lassmann; C Rene Leemans; Gerard Mamelle; Mark McGurk; Jann Mortensen; Tito Poli; Taimur Shoaib; Philip Sloan; Jens A Sorensen; Sandro J Stoeckli; Jorn B Thomsen; Giusepe Trifiro; Jochen Werner; Gary L Ross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.